Developing next generation treatments to preserve vision for patients with diseases affecting the back of the eye

Plasma Kallikrein Mediates Vascular Endothelial Growth Factor-Induced Retinal Dysfunction and Thickening.

Clermont,A., Murugesan,N., Zhou,Q., Kita,T., Robson,P.A., Rushbrooke,L.J., Evans,D.M., Aiello,L.P., and Feener,E.P. 2016. Plasma Kallikrein Mediates Vascular Endothelial Growth Factor-Induced Retinal Dysfunction and Thickening. Invest Ophthalmol. Vis. Sci. 57, 2390-2399.